Sanofi-Aventis Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Sanofi-Aventis (formerly Sanofi-Synthelabo) on December 16, 2004, for the month of December 2004. The filing serves to announce the company's financial calendar for the first half of 2005.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural announcement regarding future reporting dates rather than a financial results report.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely outlines the schedule for upcoming disclosures.
Guidance, Outlook, and Management Commentary
Management has established the following schedule for future financial communications:
- January 26, 2005: Release of Fourth Quarter and Full-Year 2004 Sales.
- March 1, 2005: Release of 2004 Full-Year Results and an Analyst/Investor meeting in Paris.
- March 21, 2005: Analyst/Investor meeting in New York.
- May 13, 2005: Release of First Quarter 2005 Sales and Earnings.
All events are scheduled to be broadcast live at the company's website. The calendar for the remainder of 2005 will be communicated subsequently.
Key Facts for Investor Verification
- Verify the actual sales figures when the January 26, 2005, release is published.
- Confirm the full-year 2004 earnings results upon the March 1, 2005, announcement.
- Monitor the company website for updates regarding the second half of the 2005 financial calendar.